Get started
Author

Takuya Mimura

Observed names: Mimura, Takuya, T Mimura, TAKUYA MIMURA
ORCID: 0009-0001-1182-0093
Observed ORCID: 0009-0001-1182-0093
OpenAlex ID: A5084611189
Predictors of Malignant Intraductal Papillary Mucinous Neoplasm of the Pancreas
2010 · Takuya Mimura, Atsuhiro Masuda, et al. · Journal of Clinical Gastroenterology · 81
Neonatal Fc receptor for IgG (FcRn) expressed in the gastric epithelium regulates bacterial infection in mice
2011 · Y Ben Suleiman, M Yoshida, et al. · Mucosal Immunology · 53
PDF
Clinical Factors of Delayed Perforation after Endoscopic Submucosal Dissection for Gastric Neoplasms
2017 · Yoshinobu Yamamoto, Hogara Nishisaki, et al. · Gastroenterology Research and Practice · 30
PDF
Risk factors for intraoperative and delayed perforation related with gastric endoscopic submucosal dissection
2024 · Takuya Mimura, Yoshinobu Yamamoto, et al. · Journal of Gastroenterology and Hepatology · 19
PDF
Pretreatment Glasgow prognostic score as a predictor of outcomes in nivolumab-treated patients with advanced gastric cancer
2021 · Nagahiro Tokuyama, Naoki Takegawa, et al. · PLoS ONE · 19
PDF
Helicobacter heilmannii can induce gastric lymphoid follicles in mice via a Peyer's patch-independent pathway
2010 · Kentaro Nobutani, Masaru Yoshida, et al. · FEMS Immunology & Medical Microbiology · 19
PDF
IFN-γ plays an essential role in the pathogenesis of gastric lymphoid follicles formation caused byHelicobacter suisinfection
2011 · Takuya Mimura, Masaru Yoshida, et al. · FEMS Immunology & Medical Microbiology · 15
Helicobacter suis KB1 derived from pig gastric lymphoid follicles induces the formation of gastric lymphoid follicles in mice through the activation of B cells and CD4 positive cells
2011 · Koji Yamamoto, Hiroshi Tanaka, et al. · Microbes and Infection · 13
The impact of nutritional status in nivolumab-treated patients with advanced esophageal cancer
2023 · Naoki Takegawa, Taku Hirabayashi, et al. · PLoS ONE · 8
PDF
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma
2023 · Yoshihiko Yano, Atsushi Yamamoto, et al. · JGH Open · 5
PDF
Polypoid leiomyosarcoma of the esophagus treated by endoscopic submucosal dissection
2015 · Yoshinobu Yamamoto, Hogara Nishisaki, et al. · Digestive Endoscopy · 5
Current Status of Conversion Hepatectomy After Sorafenib and Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma
2024 · SHOHEI KOMATSU, YOSHIHIKO YANO, et al. · Anticancer Research · 3
Significance of post‐progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma
2022 · Yoshihiko Yano, Atsushi Yamamoto, et al. · JGH Open · 3
PDF
Constrictive pericarditis caused by a pericardial-occupying tumor due to esophageal cancer
2014 · Saeko Kushida, Naoki Takekawa, et al. · Clinical Journal of Gastroenterology · 3
A Retrospective Study of Weekly Paclitaxel as Second-Line Treatment for Advanced or Recurrent Esophageal Cancer
2014 · Takeshi Sakamoto, Naoki Takegawa, et al. · Annals of Oncology · 2
Su1488 Long-Term Outcomes of Endoscopic Submucosal Dissection for M3 or SM Superficial Esophageal Squamous Cell Carcinoma Without Surgical Treatment
2013 · Ikuya Miki, Saeko Kushida, et al. · Gastrointestinal Endoscopy · 1
Pretreatment Glasgow prognostic score as a predictor of outcomes in nivolumabtreated patients with advanced gastric cancer
2021 · Nagahiro Tokuyama, Takegawa, Naoki, et al. · Figshare
Sa1248 EFFICACY OF PHOTODYNAMIC THERAPY USING TALAPORFIN SODIUM AND A DIODE LASER AS SALVAGE TREATMENT FOR LOCAL FAILURE AFTER RADIOTHERAPY OR CHEMO RADIOTHERAPY FOR ESOPHAGEAL CANCER
2020 · Yoshinobu Yamamoto, Michiko Nishikawa, et al. · Gastrointestinal Endoscopy
PDF
Pretreatment Glasgow prognostic score as a biomarker of outcomes in nivolumab-treated patients with advanced gastric cancer
2020 · Nagahiro Tokuyama, Takegawa, Naoki, et al. · Figshare
Patient Management of Laserphyrin PDT for Esophageal Cancer
2019 · Yoshinobu Yamamoto, Takuya Mimura, et al. · Nippon Laser Igakkaishi
PDF
A retrospective analysis of S-1 in patients with Gemcitabine plus nab-Paclitaxel refractory pancreatic cancer
2017 · Hidetaka Tsumura, Hideki Sakai, et al. · Annals of Oncology
PDF
Works count: 21
Citation count: 279
H-index: 8
I10-index: 8
Year
Topic
Type